The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatments, with the FDA approval of Eli Lilly’s Zepbound. The company has announced the once-a-week injectable drug's cost, dosages, insurance subsidies and when it will be on shelves.
